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Perceived occurrence of an adverse event
affects patient-reported outcomes after
total hip replacement
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Michael R. Whitehouse1,2
Abstract
Background: Dislocation, periprosthetic fracture and infection are serious complications of total hip replacement
(THR) and which negatively impact on patients’ outcomes including satisfaction, quality of life, mental health and
function. The accuracy with which patients report adverse events (AEs) after surgery varies. The impact of patient
self-reporting of AEs on patient-reported outcome measures (PROMs) after THR is yet to be investigated. Our aim
was to determine the effect of confirmed and perceived AEs on PROMs after primary THR.
Methods: A prospective single-centre cohort study of patients undergoing primary THR, with one-year follow-up,
was performed. Participants completed forms pre-operatively and 3, 6, 9 and 12 months post-operatively, including
Work Productivity and Activity Impairment (WPAI), Western Ontario and McMaster Universities Osteoarthritis Index
(WOMAC), EuroQol-5D-3 L (EQ5D), Self-Administered Patient Satisfaction (SAPS) and AE reporting questionnaires.
Results were reported in three groups: No AE, reported but not confirmed AE and confirmed AE. A generalised
linear model was used to compare among groups using robust standard errors (SE).
Results: Forty-one AEs were reported in a cohort of 417 patients (234 females), with 30 AEs reported by 3 months.
Eleven (27 reported) infections, two (six reported) periprosthetic fractures and two (eight reported) dislocations
were confirmed. Those in the no AE group reported significantly better outcomes that the reported AE group as
measured by WOMAC Co-Eff 14.27 (p = 0.01), EQ5D − 0.128 (p = 0.02) and SAPS − 9.926 (p = 0.036) and the
combined reported and confirmed AE groups as measured by WOMAC Co-Eff 13.72 (p = 0.002), EQ5D − 0.129 (p =
0.036) and SAPS − 11.512 (p = 0.004). No significant differences were seen in WPAI among groups.
Conclusions: Patients who report AEs have worse outcomes than those who do not, regardless of whether the AEs
can be confirmed by standard medical record review methods. The observed negative trends suggest that patient
perception of AEs may influence patient outcome in a similar way to those with confirmed AEs.
Keywords: Total hip replacement, Outcomes, Adverse events, Patient reporting
Introduction
In England and Wales approximately 97,000 primary
total hip replacements (THR) were performed during
2017 [1]. Demand for THR is likely to increase with an
ageing population [2, 3]. THR is a successful option for
the treatment of chronic hip pain with 90% of patients
satisfied with their outcome [4]. Dislocation, peripros-
thetic fracture and infection are relatively rare but ser-
ious complications of THR. They often require hospital
admission, further major operations and ongoing
hospital-based care posing a significant burden both to
the patient and health care system [5–7].
Adverse events (AEs) significantly impact on patients’
outcomes after THR. Dislocation, particularly recurrent
dislocations, can negatively impact on patient satisfac-
tion, quality of life, mental health and function, includ-
ing self-care and daily activities [8]. After post-operative
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periprosthetic fracture, approximately 50% of patients
do not return to previous levels of mobility and half re-
quire assistance with daily living [9]. Prosthetic joint in-
fection often requires major revision surgery and
patients experience deeply negative changes in their
quality of life enduring severe pain, long periods of im-
mobility, an inability to participate in daily work and
leisure activities, social isolation and psychological suf-
fering [10, 11]. In one study, patients with prosthetic
joint infection reported poorer outcomes on the West-
ern Ontario and McMaster Universities Osteoarthritis
Index (WOMAC), Assessment of Quality of Life
(AQoL) and the 36-Item Short Form (SF-36), and 12%
of patients rating their current situation equivalent to,
or worse than, death [12].
AEs reported by patients may provide information
about subjective experiences following a surgical proced-
ure but often reveal different results from AEs recorded
in medical records. The accuracy with which patients re-
port AEs after surgical procedures varies widely in the
literature. Concordance between patient reports and
medical records is between 0 and 58% at 30 days after all
surgical procedures [13] and 36–95% at 3 years after hip
and knee replacement [14]. Agreement between patient
reports and insurance claims after orthopaedic proce-
dures showed poor to moderate agreement (kappa 0 to
0.53) for complications, [15] rising to 69% agreement
when patients are telephoned to confirm AEs reported
via mail surveys [16].
Previous studies have evaluated the accuracy with
which patients report AEs after joint replacement sur-
gery and the impact of the most common AEs on
patient-reported outcome measures (PROMs) [13–16].
However, the impact of self-reporting of an AE on
PROMs after THR is yet to be investigated.
The aim of this study was to evaluate the effect of per-
ceived and confirmed adverse events on patient-reported
outcome measures over the first 12 months after primary
THR.
Patients and methods
A prospective single-centre cohort study was conducted
examining the impact of patient reporting of AEs on
PROMs following primary THR. Consecutive patients
undergoing a primary THR between January 2012 and
January 2013 were screened for eligibility prior to at-
tending a preoperative assessment outpatient appoint-
ment. Patients meeting the inclusion criteria were
invited to participate at this appointment. Patients were
eligible for inclusion if they were due to undergo pri-
mary elective THR, were able to provide consent to par-
ticipate and were able to understand and complete the
English language questionnaires. Exclusion criteria were
patients undergoing revision arthroplasty, patients who
were unwilling or unable to provide consent and patients
who were unable to understand or complete the ques-
tionnaires [Fig. 1]. Participation was voluntary, and pa-
tients provided verbal consent to participate. This study
was part of a larger service evaluation project of THR
and total knee replacement in this centre and ethical ap-
proval was not required according to the National
Research Ethics Service guidelines. Participants were
asked to complete questionnaires at five timepoints:
pre-operatively and at 3, 6, 9 and 12 months post-
operatively. Clinical follow-up and post-operative re-
habilitation were determined by the treating surgeon
and not affected by inclusion in this study. The pre-
operative questionnaire assessed work status using the
Work Productivity and Activity Impairment (WPAI),
[17] hip function using the WOMAC [18] and health-
related quality of life using the EuroQol-5D-3 L (EQ5D)
[19]. The post-operative questionnaire included all the
pre-operative questionnaires as well as the Self-
Administered Patient Satisfaction scale (SAPS) [20] and
an AE reporting questionnaire. The pre-operative ques-
tionnaire was administered and completed at a pre-
operative assessment outpatient appointment, no more
than 60 days prior to the date of the primary THR. Post-
operative questionnaires were posted to participants,
Fig. 1 Study flow diagram
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and if no response was received in 2 weeks, a reminder
was sent.
The WPAI is an instrument to measure impairment in
both paid and unpaid work. It can be adapted to meas-
ure absence and impairment due to a specific health
problem [17]. A score displayed as a percentage may be
calculated for work time missed, impairment while
working, overall work impairment and activity impair-
ment due to the health problem. The WPAI was com-
pleted by participants in employment. The percentage
activity impairment represents the degree to which the
hip due to be or that had been replaced affected regular
activities.
WOMAC is a 24-item questionnaire designed to
measure pain, function and stiffness in patients with
osteoarthritis of the hip or knee [18]. It uses a 5-point
Likert scale from 0 to 4 for each question (giving a
total scale of 0–96) with higher scores indicating
worse outcomes. A percentage score for each subscale
of the WOMAC and a total was calculated, giving a
score out of 100 for stiffness, pain, function and total
WOMAC score.
EQ5D is a standardised, non-disease specific question-
naire for evaluating health-related quality of life in five
dimensions, including mobility, self-care, usual activities,
pain or discomfort and anxiety or depression [19]. The
EQ5D index is derived from a standardised value set to
provide a single value for health status, where one repre-
sents full health.
SAPS is a short questionnaire used to evaluate patient
satisfaction with total hip and knee replacement [20].
Four items are scored on a 4-point Likert scale with re-
sponses from very dissatisfied to very satisfied. The scale
score is the unweighted mean of the scores with 100 be-
ing most satisfied and 25 the least.
Study-specific questionnaires were used to evaluate
AEs. Participants were asked if they had any problem
with infection in the joint or wound, a dislocation of the
THR or a fracture around the THR, after their surgery.
Participants were asked to record details of these events
and were asked if any other complications had occurred
[Appendix 1]. The first report of an AE episode was
counted, in the case of infection, if there was an infec-
tion that persisted and hence reported at multiple time
points, it was only counted once.
For AEs reported by participants hospital systems and
primary care records were interrogated to see if the AE
could be confirmed. Hospital medical records were
searched for hospital admissions and discharge docu-
mentation, outpatient clinic letters, operation records,
radiology and microbiology reports. Local picture archiv-
ing and communications imaging systems were searched
for evidence of dislocation or periprosthetic fracture.
Primary care records were searched for documentation
of an AE, post-operative general practice attendance or
antibiotic prescribing at the time of the recorded AE.
Missing data were handled according to the user guide
for each PROM. Data were analysed using STATA (ver-
sion 13, StataCorp, College Station, TX, USA). Results
are reported in three groups of participants:
1) No AE group: participants who reported no AE.
2) Reported group: participants who reported an AE
which was not confirmed after searching medical re-
cords as described above.
3) Confirmed AE group: participants who reported an
AE that was confirmed after medical record search.
Data were checked for normal distribution using a
Shapiro-Wilks test and histogram plots. Where data
were not normally distributed, central tendency is de-
scribed as median value with inter-quartile range (IQR).
PROMs data were compared among groups at 12
months using a generalised linear model(GLR) with ro-
bust standard errors (SE) in order to account for the
non-normal distribution of data. The models were ad-
justed to account for age, gender and body mass index
(BMI). The first model describes the relationship of the
no AE group to the reported group and the confirmed
group. The second model was constrained to assume no
difference between the reported and confirmed groups
and the Akaike information criteria (AIC) between the
models were then compared using a likelihood ratio test
(LRtest). A p-value of < 0.05 was considered statistically
significant.
Results
Pre-operatively 549 patients were invited to participate
and 417 were recruited. At first follow-up 322 responses
were received. By 12months, there were a further 27
non-responders and six participants withdrew from the
study.
Baseline demographics and PROMs scores are dis-
played in Table 1 and were similar among the groups.
Forty-one AEs were reported by 35 participants with
three participants reporting two AEs and one participant
reporting four (Table 2).
Most (n = 30) AEs were reported by 3 months post-
operation. Fifteen AEs were confirmed by a review of
medical records and 26 could not be confirmed. Eleven
AEs were identified on review of secondary care records
and a further four, all superficial wound infections
treated by the GP, were identified after review of pri-
mary care records. Infection was the most commonly re-
ported AE, with the majority (24 of 27) reported at 3
months. Eleven infections were confirmed, 10 were
superficial wound infections and one a prosthetic joint
infection.
Pre-operatively, PROMs were similar across each of
the three groups, except for the EQ5D which was lower
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in the confirmed AE group. All outcomes in all groups
improved with time (Table 3).
All PROMs showed the greatest improvement in the
first 3 months post-operatively. At each post-operative
time point, the confirmed AE and reported AE group
showed less improvement than the no AE group for
WOMAC, EQ5D and SAPS (Fig. 2). By 6 months the no
AE and reported AE groups had no activity impairment
associated with their THR.
PROMs at the end-point of 12 months were compared
among groups (Table 4).
Both the WOMAC and EQ5D demonstrated a signifi-
cantly better score for the no AE group when compared
to the reported groups. Both WOMAC and EQ5D dem-
onstrated a significantly improved between the no AE
group and the reported and confirmed groups in the
constrained model and the AIC and LRtest indicate
equivalence between the reported and confirmed groups.
The no AE group showed significantly better satisfaction
than the reported and confirmed groups and the com-
parison of models suggests there may be a difference
among all three results. WPAI demonstrated no signifi-
cant differences among groups.
Discussion
In this study, 41 AEs were reported by 35 patients from
a cohort of 417 patients undergoing primary THR.
Fifteen of the reported AEs were confirmed by primary
and secondary care medical records. Most AEs were re-
ported by 3 months post-operatively. Eleven infections,
two periprosthetic fractures and two dislocations were
confirmed. Participants in the reported AE group and
confirmed AE group had similar PROMs at each time-
point, worse than those who did not report an AE.
Three quarters of reported and two thirds of con-
firmed AEs were reported by 3 months. Most studies
have differing follow-up end points, and early reporting
of AEs varies. Blom et al. reported 64% of dislocations
occur within the first 3 months with 8–11 year follow-up
[6] and Phillips et al. reported 90% of dislocations and
85% of infections had occurred within 3 months, with
follow-up of 6 months [21]. Infection represented 11 of
12 confirmed AEs at 3 months, 10 of which were super-
ficial wound infections. Surgical site infection after total
hip and knee replacement is diagnosed at a median 17
(11–23) days post-operatively [22] and Lamagni reported
that 85% of infections occur within the first 30 days of
surgery [23]. In this study, none of the confirmed super-
ficial wound infections were subsequently revised for
deep prosthetic infection. Reporting of periprosthetic
fractures follows a different pattern, with half of all frac-
tures occurring intra-operatively, 24% of which are iden-
tified post-operatively [24]. In our study, fractures
identified at the time of operation were excluded,
Table 1 Patient demographics and baseline data. (IQR: interquartile range, BMI: body mass index, WPAI: Work Productivity and
Activity Impairment, EQ5D: EuroQol-5D-3 L, WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index, SAPS: Self-
Administered Patient Satisfaction scale)
Variable No Adverse Event
(n = 382)
Reported
(n = 20)
Confirmed
(n = 15)
All participants
(n = 417)
Age (IQR) 68 (57, 75) 61 (57, 75) 67 (50, 75) 67 (57, 75)
Female sex (%) 213 (56%) 12 (60%) 8 (53%) 234 (56%)
BMI (IQR) 28 (25, 31) 33 (29, 36) 30 (26, 35) 28 (25, 32)
Retired (%) 222 (60%) 17 (55%) 7 (50%) 240 (59%)
WPAI (IQR) 70 (50, 80) 70 (70, 90) 65 (40, 80) 70 (50, 80)
EQ5D (IQR) 0.52 (0.06, 0.70) 0.52 (0.6, 0.62) 0.16 (0.02, 0.69) 0.52 (0.6, 0.69)
WOMAC (IQR) 59.9 (50, 69.8) 60.1 (54.2, 77.1) 59.4 (55.2, 70.8) 59 (50, 70)
Table 2 Adverse events by group, reported but not confirmed or confirmed adverse event and timepoint reported. Note: the
number of AE (41) is greater than the number of participants that reported AE (35) as some reported more than one event
INFECTION PERIPROSTHETIC FRACTURE DISLOCATION TOTAL
ADVERSE EVENTS Reported Confirmed Reported Confirmed Reported Confirmed Reported Confirmed
3 MONTHS 13 11 2 1 3 0 18 12
6 MONTHS 1 0 1 0 1 1 3 1
9 MONTHS 2 0 0 1 0 1 2 2
12 MONTHS 0 0 1 0 2 0 3 0
TOTAL 16 11 4 2 6 2 26 15
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however both confirmed fractures occurred at the time
of surgery but were not reported until subsequent
follow-up. Post-operative periprosthetic fracture occurs
in 1.7% of primary THR with a linear survival curve over
10 years, suggesting that the rate of fracture does not
change over time [25]. The timing of the AEs reported
in our study are in keeping with the published literature.
Fifteen of a reported 41 AEs were confirmed in our
study. There are differences between self-reported AE
rates and those confirmed by medical records, but rates
vary in the literature. One study confirming patient-
reported post-operative complications using medical re-
cords found agreement in 0–41% of cases [13]. Surgical
site infection had agreement (kappa) of 0.53 (95%CI,
0.17 to 0.89) and 0 for fracture/dislocation in a study of
internet-based patient reporting across orthopaedic
procedures [15]. Agreement tends to be higher when
patients are contacted by telephone to confirm compli-
cations which may represent confounding as patients are
confirming their own self-reports. However, it may be
that patients misreport AE due to lack of comprehension
or literacy when asked to complete a questionnaire, ra-
ther than by an interviewer. When patients were con-
tacted by telephone by a surgeon, to confirm reported
AEs, a concordance of 69% was achieved [16]. Alazzawi
et al. confirmed 95% of infections, 52% of dislocations
and 57% of periprosthetic fractures after primary hip
and knee replacement using medical record review and
surveying general practitioners [14]. Our overall
agreement of 37% is at the lower end of the spectrum re-
ported to date. Most of the reported AEs in our study
were not confirmed on review of medical records. Fritz
et al. discovered that participants may accurately report
a complication that occurred after surgery which may
not have been documented in the medical records [13].
Greenbaum identified that 72% of patients with disloca-
tion and 7% of fractures present to an outside hospital
after THR [16]. Despite rigorous exploration of regional
medical records, some AEs may not have been con-
firmed if patients presented to hospitals outside the re-
gion, but these should still have been captured by
primary care records as hospitals are required to report
admissions to hospital to the primary care physician and
this, in turn, is documented in the primary care records.
However, most unconfirmed AEs are explained by pa-
tients who report an AE that did not occur. Reasons for
these reports include misinterpretation of symptoms as
AEs, erroneously reporting an AE that did not occur or
accurately reporting an AE that occurred prior to sur-
gery [13, 16]. A large portion of patients reporting an
AE, misreport the occurrence of AEs after THR. Regard-
less of the reason, self-reporting of an AE appears to be
associated with outcome. Studies using medical record
review to identify AEs after surgery may, therefore,
underestimate the number of patients negatively im-
pacted by their surgical procedure.
In this study, participants who reported an AE had
outcomes similar to those with a confirmed AE. Both
Table 3 A comparison of patient reported outcomes over time by group. (AE: adverse event, IQR: interquartile range, WPAI: Work
Productivity and Activity Impairment, EQ5D: EuroQol-5D-3 L, WOMAC: Western Ontario and McMaster Universities Osteoarthritis
Index, SAPS: Self-Administered Patient Satisfaction scale)
Pre-op
Median (IQR)
3 Months
Median (IQR)
6 Months
Median (IQR)
9 Months
Median (IQR)
12 Months
Median (IQR)n n n n n
WPAI
No AE 70 (50,80) 106 20 (10,30) 76 10 (0,20) 71 0 (0,20) 68 0 (0,20) 72
Reported 70 (70,90) 6 25 (10,30) 6 0 (0,10) 3 0 (0,50) 3 0 (0,20) 3
Confirmed 65 (40,80) 4 30 (20,40) 4 20 (0,20) 3 20 5,30) 4 15 (5,25) 4
EQ5D
No AE 0.52 (0.6, 0.69) 395 0.76 (0.62, 1) 313 0.8 (0.69, 1) 298 0.81 (0.69, 285 0.88 (0.71, 1) 289
Reported 0.52 (0.16, 0.59) 18 0.62 (0.52, 0.76) 17 0.7 (0.55, 0.91) 16 0.7 (0.62, 0.78) 14 0.7 (0.52, 0.82) 14
Confirmed 0.16 (0.02, 0.69) 15 0.59 (0.36,0.76) 15 0.75 (0.64, 1) 12 0.7 (0.22, 0.91) 12 0.76 (0.71, 1) 13
WOMAC
No AE 59.9 (50, 69.8) 364 16.7 (8.3, 31.2) 269 12.5 (4.4, 27.1) 267 10.4 (3.1, 23) 256 7.3 (2.1, 16.8) 256
Reported 60.1 (54.2, 77.1) 18 29.2 (15.2, 40.1) 16 22.9 (8.3, 50) 17 26 (12.5, 40.1) 16 22.4 (7.3, 46.9) 14
Confirmed 59.4 (55.2, 70.8) 15 25.9 (15.6, 51) 15 21.7 5.2, 33.3) 11 26.5 (6.5, 29.9) 12 15.6 (5.2, 29.1) 13
SAPS
No AE 93.8 (81.3, 100) 268 100 (81.3, 100) 250 100 (81.3, 100) 247 100 (87.5, 100) 248
Reported 78.1 (75, 100) 18 87.5 (68.8, 100) 17 93.8 (75, 100) 15 87.5 (75, 100) 14
Confirmed 81.3 (68.8, 100) 13 81.3 (71.9, 100) 12 87.5 (62.5, 100) 12 81.3 (62.5, 100) 11
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Fig. 2 PROMs by adverse event group and timepoint. (WPAI: Work Productivity and Activity Impairment; WOMAC: Western Ontario and McMaster
Universities Osteoarthritis Index; EQ5D:EuroQol-5D-3 L)
Table 4 A comparison of patient reported outcome measures among groups at 12-months; Model 1: GLR describing the
relationship of the no AE group to the reported group and the confirmed group. Model 2: GLR describing the relationship of the no
AE group to the reported and confirmed group, when constrained to assume no difference between these two groups. Group 1: No
AE group, Group 2: Reported group, Group 3: Confirmed group. (WOMAC: Western Ontario and McMaster Universities Osteoarthritis
Index, EQ5D: EuroQol-5D-3 L, SAPS: Self-Administered Patient Satisfaction scale, WPAI: Work Productivity and Activity Impairment)
PROM Model Groups Co-efficient 95%CI p-value AIC LRtest
WOMAC Model 1: 1 to 2 14.27 (3.2, 25.3) p = 0.01 8.5
1 to 3 13.13 (−0.68, 26.9) p = 0.06
Model 2: 1 to (2 and 3) 13.72 (4.8, 22.6) p = 0.002 8.49 0.85
EQ5D Model 1: 1 to 2 −0.128 (− 0.25, − 0.006) p = 0.04 0.015
1 to 3 −0.129 (−0.34, 0.079) p = 0.22
Model 2: 1 to (2 and 3) −0.1285 (0.25, −0.008) p = 0.036 0.0081 0.9
SAPS Model 1: 1 to 2 −9.926 (−19.2, −0.7) p = 0.036 8.11
1 to 3 −13.5 (−26.6, −0.5) p = 0.042
Model 2: 1 to (2 and 3) −11.515 (−19.4, −3.7) p = 0.004 8.1 0.5
WPAI Model 1: 1 to 2 −6.805 (−18.7, 5.2) p = 0.264 9.05
1 to 3 1.53 (−1.7, 13.7) p = 0.806
Model 2: 1 to (2 and 3) −2.043 (−11.9, 7.82) p = 0.685 9.03 0.6
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WOMAC and EQ5D demonstrated equivalence between
the reported and confirmed groups. SAPS, WOMAC
and EQ5D have been shown to be significantly worse in
the reported and confirmed groups compared to those
with no AE. Self-reporting an AE may be due to patient
perception of an AE that did not occur. This appears to
negatively impact on outcome. The nocebo effect, a
negative expectation derived from a clinical encounter,
can adversely influence quality of life. Clinician disclos-
ure about potential side effects of medications can itself
contribute to reporting AEs, but this effect has not been
investigated in the surgical setting [26]. The cyclical na-
ture of negative perceptions around health, mental well-
being and outcomes are echoed by Perrucio et al. who
demonstrated that worse self-reported general health
scores predicts less improvement after THR. The pa-
tient’s perception of health predicts future physical,
mental and social outcomes, and this in turn is predicted
by the patient’s mental well-being [27]. The negative
trends seen across WOMAC, EQ5D and patient re-
ported satisfaction, in this study, suggest that patient
perception of AEs may influence health outcome.
One aspect that was not investigated as part of this
study were the effects of depression on the perception of
an AE. Patients with depression have worse pre and post-
operative pain and functional scores but experience the
same benefit from THR than those without [28, 29]. The
complex interplay of mental well-being, patient percep-
tions and the impact of AEs with patients’ outcomes after
THR requires further investigation. Understanding patient
perception and identification of AEs may be more thor-
oughly investigated using qualitative methods designed to
gain an in-depth understanding of patients’ understanding
of AE, experiences, opinions regarding healthcare and the
impact of these AEs. An investigation of the impact of de-
pression may further explain the trends we have reported.
The findings in this study are generalisable as the
baseline demographics of participants in this study are
similar to those reported to in the National Joint Regis-
try for England, Wales and Northern Ireland and the Isle
of Man [1]. At 12 months, 23% of questionnaires sent to
patients were not returned, despite sending out re-
minders. Although a similar non-response level to previ-
ous studies, this may affect the internal validity of the
study and thus result in some selection bias [15, 30].
The number of AEs reported and confirmed within this
study was relatively small and thus the results of this
study should be interpreted with caution. A larger study
sample may improve the statistical certainty with which
the results can be interpreted.
Conclusion
In conclusion, patients who report AEs (8%, n = 35) have
worse outcomes than those who do not. Self-reporting
of an AE appears to have a similarly negative impact on
outcomes to those with a confirmed AE. Clear informa-
tion regarding risks and potential AEs, is required, not
only for consent, but to ensure patients can correctly
identify AEs should they occur. Patients who perceive
that they have an AE may require careful monitoring
and support.
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